Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SHE:301093)
China flag China · Delayed Price · Currency is CNY
81.90
-4.41 (-5.11%)
Feb 11, 2026, 4:00 PM EST

SHE:301093 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
602.9584.45621.9583.67819.27443.65
Other Revenue
1.961.961.030.471.62.67
604.86586.41622.92584.14820.87446.32
Revenue Growth (YoY)
2.18%-5.86%6.64%-28.84%83.92%-2.92%
Cost of Revenue
375.9363.66367.57334.13373.85240.55
Gross Profit
228.96222.76255.36250447.02205.77
Selling, General & Admin
145.73145.52145.13139.3141.476.23
Research & Development
40.239.5436.1836.6942.0823.66
Other Operating Expenses
5.854.063.416.148.826.14
Operating Expenses
192.93189.58183.67183.7194.68106.5
Operating Income
36.0333.1871.6866.3252.3499.27
Interest Expense
-0.81-0.25-0.44-0.6-4.83-6.8
Interest & Investment Income
11.0322.0548.214.893.740.24
Currency Exchange Gain (Loss)
-2.81-2.811.951.40.72-1.37
Other Non Operating Income (Expenses)
4.1-0.58-0.42-0.27-1.31-0.95
EBT Excluding Unusual Items
47.5451.58120.9781.72250.6690.38
Gain (Loss) on Sale of Investments
10.585.853.2625.83--
Gain (Loss) on Sale of Assets
-0.5600.210.27-0.021.51
Asset Writedown
1.22-0.05-0.04-0.84--
Other Unusual Items
1.171.1712.870.352.383.87
Pretax Income
59.9558.55137.27107.33253.0295.76
Income Tax Expense
9.398.9819.3413.583714.41
Earnings From Continuing Operations
50.5649.57117.9393.75216.0281.36
Minority Interest in Earnings
0.090----
Net Income
50.6549.57117.9393.75216.0281.36
Net Income to Common
50.6549.57117.9393.75216.0281.36
Net Income Growth
-37.36%-57.96%25.79%-56.60%165.52%-14.52%
Shares Outstanding (Basic)
164167175175139131
Shares Outstanding (Diluted)
164167177175139131
Shares Change (YoY)
-3.81%-5.83%0.98%26.34%5.62%-0.10%
EPS (Basic)
0.310.300.670.541.560.62
EPS (Diluted)
0.310.300.670.541.560.62
EPS Growth
-34.88%-55.36%24.56%-65.65%151.39%-14.44%
Free Cash Flow
-63.37-14.65-73.39-78.7392.7893.86
Free Cash Flow Per Share
-0.39-0.09-0.41-0.450.670.71
Dividend Per Share
0.1540.1540.4620.2310.538-
Dividend Growth
-66.67%-66.67%99.70%-57.08%--
Gross Margin
37.85%37.99%40.99%42.80%54.46%46.10%
Operating Margin
5.96%5.66%11.51%11.35%30.74%22.24%
Profit Margin
8.37%8.45%18.93%16.05%26.32%18.23%
Free Cash Flow Margin
-10.48%-2.50%-11.78%-13.48%11.30%21.03%
EBITDA
99.5888.54116.13101.15280.45128.72
EBITDA Margin
16.46%15.10%18.64%17.32%34.16%28.84%
D&A For EBITDA
63.5555.3644.4534.8428.1129.45
EBIT
36.0333.1871.6866.3252.3499.27
EBIT Margin
5.96%5.66%11.51%11.35%30.74%22.24%
Effective Tax Rate
15.66%15.33%14.09%12.65%14.62%15.04%
Revenue as Reported
604.86586.41622.92584.14820.87446.32
Advertising Expenses
-0.531.072.571.69-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.